Quoting from Penny Parker's new column, Mile High Life, in Denver's suburban newspaper consortium, Our Colorado News:
"Cat lovers can grab a kitty by the tail during Tails of the Painted Cats 2012, an auction and purr-fect dinner and gala July 28 at Lakewood Country Club to benefit the Cat Care Society...
...The event emcee is Ed Greene, CBS4 weather whiz. Auctioneers are Warren and Terri Smith of Two for the Show Auctions. Individual tickets for the gala are $75. New this year is a $100 patron ticket to a private VIP meet-and-greet prior to the dinner, where Greene will sign the 2013 "weather cat" painted cat.
The silent auction at the gala will include a Tower of Wine with 36 bottles (including pricey French labels and Marilyn Merlots) that attendees can bid on in addition to the Painted Cats...
...Tickets for the July 28 gala dinner and auction are available at: https://events.r20.constantcontact.com"
Link to Penny's column and pictures of several of the Painted Cats
Link to the Photo Gallery
Friday, July 27, 2012
Wednesday, July 11, 2012
9News Denver: 'Colo. bioscience industry, patients to benefit from new law'
CBSA Pres/CEO Holli Riebel interviewed with 9News yesterday regarding the new federal law that cuts the FDA's approval timetable for new drugs. Quoting from the 9News posting:
"Supporters say the bill would benefit hundreds of Colorado startups that are developing novel medicines and therapies. They say the provision could also help severely ill patients who are willing to take experimental drugs that haven't undergone the full battery of tests for all possible side effects and complications...
...About 600 bioscience companies, research institutions and venture capital groups in Colorado employ about 20,000 people, and the industry continues to grow despite the sluggish economy, according to the Colorado Bioscience Association."
Link to the video report or view here:
http://www.9news.com/rss/story.aspx?storyid=277012
"Supporters say the bill would benefit hundreds of Colorado startups that are developing novel medicines and therapies. They say the provision could also help severely ill patients who are willing to take experimental drugs that haven't undergone the full battery of tests for all possible side effects and complications...
...About 600 bioscience companies, research institutions and venture capital groups in Colorado employ about 20,000 people, and the industry continues to grow despite the sluggish economy, according to the Colorado Bioscience Association."
Link to the video report or view here:
http://www.9news.com/rss/story.aspx?storyid=277012
Tuesday, July 3, 2012
LifeScience: 'Aurora Bioscience district gets new boss with big experience'
Quoting from the July 3 Aurora Sentinel article by Brandon Johansson:
"Steve VanNurden is excited for the new expansion wing at the Bioscience Park Center, Thursday afternoon, June 28, at the Fitzsimons Life Science District. VanNurden took over as President and CEO in late May...
...That growth and the momentum he sees being built was what drew VanNurden from Mayo Clinic Ventures in Rochester, Minn. to the FRA.
VanNurden started at Mayo 22 years ago after a career with agriculture-industry giant Cargill.
A few years prior, Mayo had launched Mayo Clinic Ventures, which aimed to take the world-class research happening at Mayo, and turn it into bioscience and biotechnology companies.
Since then, he helped start about 50 individual companies.
That ability to take the ideas that sprout from medical research and turn them into profitable companies has local officials excited about VanNurden’s arrival at the FRA.
Mark Spiecker, CEO of Sharklet Technologies, one of the 39 companies at the FRA’s Bioscience Park Center, said VanNurden is the perfect fit for the organization.
Across the health-care industry, Mayo is seen as a model for technology development and funding, Spiecker said, and Mayo Clinic Ventures is well-known as a place where breakthrough technologies become startup companies.
'Having a guy that used to run that program is a great opportunity for us,' he said.
Holli Riebel, CEO of the Colorado Bioscience Association, said landing VanNurden was a sign that Colorado’s burgeoning bioscience industry is gaining credibility around the country. 'I think it’s a real coup for us to be able to attract Steve,' she said.
His background with starting bioscience companies will be ideal at the FRA, where officials have announced an enhanced focus on building relationships with the rest of the state’s bioscience industry, she said.
'That’s really what we’re trying to do,' she said."
Link to the full article
"Steve VanNurden is excited for the new expansion wing at the Bioscience Park Center, Thursday afternoon, June 28, at the Fitzsimons Life Science District. VanNurden took over as President and CEO in late May...
...That growth and the momentum he sees being built was what drew VanNurden from Mayo Clinic Ventures in Rochester, Minn. to the FRA.
VanNurden started at Mayo 22 years ago after a career with agriculture-industry giant Cargill.
A few years prior, Mayo had launched Mayo Clinic Ventures, which aimed to take the world-class research happening at Mayo, and turn it into bioscience and biotechnology companies.
Since then, he helped start about 50 individual companies.
That ability to take the ideas that sprout from medical research and turn them into profitable companies has local officials excited about VanNurden’s arrival at the FRA.
Mark Spiecker, CEO of Sharklet Technologies, one of the 39 companies at the FRA’s Bioscience Park Center, said VanNurden is the perfect fit for the organization.
Across the health-care industry, Mayo is seen as a model for technology development and funding, Spiecker said, and Mayo Clinic Ventures is well-known as a place where breakthrough technologies become startup companies.
'Having a guy that used to run that program is a great opportunity for us,' he said.
Holli Riebel, CEO of the Colorado Bioscience Association, said landing VanNurden was a sign that Colorado’s burgeoning bioscience industry is gaining credibility around the country. 'I think it’s a real coup for us to be able to attract Steve,' she said.
His background with starting bioscience companies will be ideal at the FRA, where officials have announced an enhanced focus on building relationships with the rest of the state’s bioscience industry, she said.
'That’s really what we’re trying to do,' she said."
Link to the full article
Sunday, July 1, 2012
NCBR: 'Colorado medical device companies grow'
Quoting from the June 29th posting:
"The number of Colorado medical device companies grew by nearly 20 percent in Colorado in the last decade, according to a new bioscience report.
Furthermore, the state showed a 16.1 percent employment growth in the medical device sector from 2001 to 2010, the nonprofit Colorado BioScience Association said Friday. The association cited data from a recent report compiled by global research and development group Battelle and the Biotechnology Industry Organization."
Link to the Northern Colorado Business Report
"The number of Colorado medical device companies grew by nearly 20 percent in Colorado in the last decade, according to a new bioscience report.
Furthermore, the state showed a 16.1 percent employment growth in the medical device sector from 2001 to 2010, the nonprofit Colorado BioScience Association said Friday. The association cited data from a recent report compiled by global research and development group Battelle and the Biotechnology Industry Organization."
Link to the Northern Colorado Business Report
Subscribe to:
Posts (Atom)